/sup 32/P testing for posterior segment lesions

Journal Article · Wed Jan 01 00:00:00 EST 1975 · Trans. Am. Acad. Ophthalmol. Oto-Laryngol.; (United States)

OSTI ID:7317406

Ruiz, R S; Howerton, Jr, E E

/sup 32/P testing introduced to ophthalmology by Thomas et al. in 1952 has gained wide acceptance as a test for determining the benign or malignant nature of ocular lesions. With experience gained during the first decade, the test was generally thought to be accurate for larger anterior lesions but unreliable in testing smaller posterior lesions. Over the last ten years new instruments utilizing modern technologic advances have been developed. Greater understanding of the basic properties of /sup 32/P and its behavior in benign and malignant tissue has been obtained. Accurate localization, improvements in instrument design, and newer surgical techniques have been employed. All of these factors have transformed /sup 32/P testing into a highly accurate and reliable procedure. If done properly, the test is accurate not only for large anterior lesions but also for smaller posterior lesions. This series will verify the reliability of /sup 32/P testing if properly performed and correctly interpreted. It will also point out the limitations and pitfalls in the procedure.

• Research Organization: Univ. of Texas Medical School, Houston
• OSTI ID: 7317406
• Journal Information: Trans. Am. Acad. Ophthalmol. Oto-Laryngol.; (United States), Vol. 79:2
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
EYES
NEOPLASMS
DIAGNOSIS
PHOSPHORUS 32
DIAGNOSTIC TECHNIQUES
PATIENTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
ISOTOPES
LIGHT NUCLEI
NUCLEI
ODD-ODD NUCLEI
ORGANS
PHOSPHORUS ISOTOPES
RADIOISOTOPES
SENSE ORGANS
550601* - Medicine- Unsealed Radionuclides in Diagnostics